Warden MR, Selimbeyoglu A, Mirzabekov JJ, Lo M, Thompson KR, Kim SY, et al
Introduction Six glucagon-like peptide 1 (GLP-1) receptor agonists (GLP-1RAs) are approved for the treatment of type 2 diabetes, including 4 long-acting agents, but only 1 (liraglutide) is approved and 1 (semaglutide) under investigation for the treatment of obesity
It works alongside elastin and other extracellular matrix components to provide firmness and resilience
Are side effects worse at higher doses
Healthy carbohydrate sources include: Whole grains (quinoa, brown rice, whole wheat bread) Fruits Vegetables Legumes Limit High-Fat Foods Fat takes longer to digest, which can cause discomfort when using GLP-1s